Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
161
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Case Report: Comprehensive Management of Pneumocystis Jiroveci Pneumonia (PJP) and Secondary Infections of Multiple-Drug Resistant Enterobacter cloacae complex and Pseudomonas aeruginosa in a Kidney Transplant Recipient with Sulfonamide Allergies

Longyin Zhu1 Department of Nephrology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0009-0006-1424-856XView further author information
ORCID Icon,
Huan Xu2 Department of Scientific Affairs, Vision Medicals Center for Infection Diseases, Guangzhou, People’s Republic of ChinaView further author information
,
Youmin Pu1 Department of Nephrology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Chunxiao Fu1 Department of Nephrology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Qianguang Pan1 Department of Nephrology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of ChinaView further author information
&
Hongwen Zhao1 Department of Nephrology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-6024-7430View further author information
ORCID Icon
Pages 6185-6193 | Received 04 Jul 2023, Accepted 07 Sep 2023, Published online: 13 Sep 2023

References

  • Zou J, Wang T, Qiu T, et al. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation. Transpl Immunol. 2022;72:101593. doi:10.1016/j.trim.2022.101593
  • Kim JE, Han A, Lee H, Ha J, Kim YS, Han SS. Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome. BMC Nephrol. 2019;20(1):212. doi:10.1186/s12882-019-1407-x
  • Iriart X, Bouar ML, Kamar N, Berry A. Pneumocystis pneumonia in solid-organ transplant recipients. J Fungi. 2015;1(3):293–331. doi:10.3390/jof1030293
  • Yu Y, Yang H, Yu X, et al. Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument. J Clin Pharm Ther. 2020;45(6):1325–1333. doi:10.1111/jcpt.13213
  • Iriart X, Challan Belval T, Fillaux J, et al. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis. Am J Transplant. 2015;15(1):190–199. doi:10.1111/ajt.12947
  • Lee SH, Huh KH, Joo DJ, et al. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. Sci Rep. 2017;7(1):1571. doi:10.1038/s41598-017-01818-w
  • Eitner F, Hauser IA, Rettkowski O, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant. 2011;26(6):2013–2017. doi:10.1093/ndt/gfq689
  • Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation. 1996;62(3):421–423. doi:10.1097/00007890-199608150-00022
  • Bateman M, Oladele R, Kolls JK. Diagnosing Pneumocystis jirovecii pneumonia: a review of current methods and novel approaches. Med Mycol. 2020;58(8):1015–1028. doi:10.1093/mmy/myaa024
  • Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med. 2021;27(1):115–124. doi:10.1038/s41591-020-1105-z
  • Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67(suppl_2):S231–S240. doi:10.1093/cid/ciy693
  • Zhang F, Chen J, Huang H, et al. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients. Eur J Clin Microbiol Infect Dis. 2021;40(9):1933–1942. doi:10.1007/s10096-021-04254-x
  • Fishman JA. Pneumocystis jiroveci. Semin Respir Crit Care Med. 2020;41(1):141–157. doi:10.1055/s-0039-3399559
  • Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients. JAMA. 1986;256(24):3358–3363. doi:10.1001/jama.1986.03380240052027
  • Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol Res. 1987;123:1160.
  • Solensky R. Drug desensitization. Immunol Allergy Clin North Am. 2004;24(3):425–443. doi:10.1016/j.iac.2004.03.008
  • Brookman D. Therapeutic guidelines: antibiotic. Version 12; 2003.
  • Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev. 2014;2014(10):CD005590. doi:10.1002/14651858.CD005590.pub3

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.